Synlogic: 50% Upside Ahead?

Today we take a look at Synlogic. This 'Tier 4' biotech concern has a deep early stage pipeline and is well-funded

Today we look at a small ‘Tier 4’ biotech concern that is undervalued by 50% or more if one believes recent…

Company Overview:


Fresh Conversations